These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin]. Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733 [TBL] [Abstract][Full Text] [Related]
3. Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. Asuquo AE; Piddock LJ J Antimicrob Chemother; 1993 Jun; 31(6):865-80. PubMed ID: 8360125 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity and accumulation of moxifloxacin in quinolone-susceptible bacteria. Piddock LJ; Jin YF J Antimicrob Chemother; 1999 May; 43 Suppl B():39-42. PubMed ID: 10382874 [TBL] [Abstract][Full Text] [Related]
6. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. Mortimer PG; Piddock LJ J Antimicrob Chemother; 1991 Nov; 28(5):639-53. PubMed ID: 1663928 [TBL] [Abstract][Full Text] [Related]
7. Lack of effect of carbonyl cyanide m-chlorophenylhydrazone on KB-5246 accumulation by Staphylococcus aureus. Kotera Y; Inoue Y; Ohashi M; Ito K; Inoue M Antimicrob Agents Chemother; 1992 Apr; 36(4):883-5. PubMed ID: 1323957 [TBL] [Abstract][Full Text] [Related]
8. [Study of quinolones resistance in Escherichia coli, Staphylococcus aureus and Pseudomonas areuginosa]. Feng P; Yu R; Xia P; Lü X; Zhu S Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):501-4. PubMed ID: 12528531 [TBL] [Abstract][Full Text] [Related]
9. Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus. Piddock LJ; Jin YF; Griggs DJ J Antimicrob Chemother; 2001 Mar; 47(3):261-70. PubMed ID: 11222558 [TBL] [Abstract][Full Text] [Related]
10. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Furet YX; Deshusses J; Pechère JC Antimicrob Agents Chemother; 1992 Nov; 36(11):2506-11. PubMed ID: 1489194 [TBL] [Abstract][Full Text] [Related]
11. Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones. Bazile S; Moreau N; Bouzard D; Essiz M Antimicrob Agents Chemother; 1992 Dec; 36(12):2622-7. PubMed ID: 1336340 [TBL] [Abstract][Full Text] [Related]
12. Quinolone resistance in potentially pathogenic and non-pathogenic Escherichia coli strains isolated from healthy ruminants. Orden JA; Ruiz-Santa-Quiteria JA; Cid D; Díez R; Martínez S; de la Fuente R J Antimicrob Chemother; 2001 Sep; 48(3):421-4. PubMed ID: 11533010 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of lomefloxacin. Piddock LJ; Hall MC; Wise R Antimicrob Agents Chemother; 1990 Jun; 34(6):1088-93. PubMed ID: 2168142 [TBL] [Abstract][Full Text] [Related]
14. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies. Fernandes PB; Swanson RN Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851 [TBL] [Abstract][Full Text] [Related]
15. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus]. Cetinkaya E; Coban AY; Durupinar B Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076 [TBL] [Abstract][Full Text] [Related]
16. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa. Pasquali F; Manfreda G Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619 [TBL] [Abstract][Full Text] [Related]
17. Accumulation of rifampicin by Escherichia coli and Staphylococcus aureus. Williams KJ; Piddock LJ J Antimicrob Chemother; 1998 Nov; 42(5):597-603. PubMed ID: 9848443 [TBL] [Abstract][Full Text] [Related]
18. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Takenouchi T; Tabata F; Iwata Y; Hanzawa H; Sugawara M; Ohya S Antimicrob Agents Chemother; 1996 Aug; 40(8):1835-42. PubMed ID: 8843290 [TBL] [Abstract][Full Text] [Related]
19. Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae. Zeller V; Janoir C; Kitzis MD; Gutmann L; Moreau NJ Antimicrob Agents Chemother; 1997 Sep; 41(9):1973-8. PubMed ID: 9303396 [TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model. Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]